Sumatriptan Nitroso Impurity

Status: Under Development

It is an impurity present in Sumatriptan, Sumatriptan is an agonist of 5-HT1B and 5-HT1D. Sumatriptan is predominantly metabolized by monoamine oxidase. The metabolites are the inactive indole acetic acid and indole acetic acid glucuronide. Sumatriptan decreases carotid arterial blood flow, but increases blood flow velocity in the internal carotid artery and middle cerebral artery, Sumatriptan is a serotonin receptor agonist commonly used to treat migraines and sometimes cluster headaches.

Additional information on Sumatriptan Nitroso Impurity

Catalogue No. VE0010178
Molecular Formula C14H20N4O3S
Molecular Weight 324.4 g/mol
Parent drug Sumatriptan
IUPAC Name 1-(3-(2-(Dimethylamino)ethyl)-1-nitroso-1H-indol-5-yl)-N-methylmethanesulfonamide
Synonyms N/A
References Derry, C. J., Derry, S., & Moore, R. A. (2014). Sumatriptan (all routes of administration) for acute migraine attacks in adults – overview of Cochrane reviews. Cochrane Database of Systematic Reviews.
Status Under Development

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Sumatriptan Nitroso Impurity

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.